Drug intelligence / Profile preview

Feminon

Development stage: Unknown
Lead developer: Ankh Pharmaceuticals
Administration: Oral

Overview

Feminon is a branded herbal supplement developed and marketed by Ankh Pharmaceuticals. It is positioned within the company's portfolio of Ayurvedic-inspired consumer products aimed at general wellness, specifically targeting women's health indications. Unlike conventional pharmaceutical agents, Feminon is a botanical formulation without a single defined molecular target or a history of formal clinical trial phases (Phase 1-3). It is sold as a consumer health product for the maintenance of physiological balance and wellness.

Brand names: Feminon
Other names: Feminon

Beyond the preview

Go deeper on Feminon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feminon.

Explore the full profile